CellaVision AB
STO:CEVI
CellaVision AB
Revenue
CellaVision AB
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
CellaVision AB
STO:CEVI
|
Revenue
kr723.2m
|
CAGR 3-Years
9%
|
CAGR 5-Years
9%
|
CAGR 10-Years
13%
|
|
|
Elekta AB (publ)
STO:EKTA B
|
Revenue
kr18.1B
|
CAGR 3-Years
10%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
S
|
Surgical Science Sweden AB
STO:SUS
|
Revenue
kr884.1m
|
CAGR 3-Years
34%
|
CAGR 5-Years
54%
|
CAGR 10-Years
N/A
|
|
|
Getinge AB
STO:GETI B
|
Revenue
kr34.8B
|
CAGR 3-Years
9%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
Arjo AB (publ)
STO:ARJO B
|
Revenue
kr11.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
S
|
Stille AB
STO:STIL
|
Revenue
kr570m
|
CAGR 3-Years
45%
|
CAGR 5-Years
29%
|
CAGR 10-Years
21%
|
|
CellaVision AB
Glance View
CellaVision AB engages in the provision of automated microscopy systems in the field of hematology. The company is headquartered in Lund, Skane and currently employs 200 full-time employees. The company went IPO on 2007-05-28. The firm develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The firm operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
See Also
What is CellaVision AB's Revenue?
Revenue
723.2m
SEK
Based on the financial report for Dec 31, 2024, CellaVision AB's Revenue amounts to 723.2m SEK.
What is CellaVision AB's Revenue growth rate?
Revenue CAGR 10Y
13%
Over the last year, the Revenue growth was 7%. The average annual Revenue growth rates for CellaVision AB have been 9% over the past three years , 9% over the past five years , and 13% over the past ten years .
You don't have any saved screeners yet